MedCity News January 12, 2026
At JPM, Nvidia unveiled partnerships with Eli Lilly, Thermo Fisher and others that show how the chipmaker is pushing its AI beyond models and into the core infrastructure of drug discovery and research labs. The moves highlight Nvidia’s ambitions to become a foundational technology provider for the pharma industry.
On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded partnerships aimed at embedding AI even deeper into drug discovery and pharmaceutical research.
Most notably, Nvidia is teaming up with Eli Lilly to launch a joint innovation lab in South San Francisco. The partners said the lab’s overarching goal is to accelerate drug discovery by applying advanced AI models to longstanding biotech challenges.
...Today's Sponsors
Today's Sponsor